Research programme: autophagy modulators - Aravive
Alternative Names: 4-series autophagy; 6-seriesLatest Information Update: 03 May 2024
At a glance
- Originator Ruga Corporation
- Developer Aravive Biologics
- Class Antineoplastics
- Mechanism of Action Autophagy modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Renal cancer